Arpin D - Search Results

1

Routine EGFR molecular analysis in non-small-cell lung cancer patients is feasible: exons 18-21 sequencing results of 753 patients and subsequent clinical outcomes.

Locatelli-Sanchez M, Couraud S, Arpin D, Riou R, Bringuier PP, Souquet PJ. Locatelli-Sanchez M, et al. Among authors: arpin d. Lung. 2013 Oct;191(5):491-9. doi: 10.1007/s00408-013-9482-4. Epub 2013 Jun 9. Lung. 2013. PMID: 23749122

2

[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer].

Trillet-Lenoir V, Lasset C, Arpin D, Bohas C, Riou R, Perol M, Fournel P, Rebattu P, Caillet B, Pacheco Y. Trillet-Lenoir V, et al. Among authors: arpin d. Bull Cancer. 1992;79(12):1173-81. Bull Cancer. 1992. PMID: 1339011 Clinical Trial. French.

3

[Value of C-reactive protein determination in small cell lung cancer].

Arpin D, Trillet-Lenoir V, Lasset C, Souquet PJ, Riou R, Yoanidis I, Guidollet J, Cordier JF, Brune J. Arpin D, et al. Bull Cancer. 1993 Dec;80(12):1063-8. Bull Cancer. 1993. PMID: 8081044 French.

4

The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer.

Trillet-Lenoir V, Soler P, Arpin D, Bohas C, Riou R, Court-Fortune I, Ecochard D, Perol M, Cordier JF. Trillet-Lenoir V, et al. Among authors: arpin d. Lung Cancer. 1996 Jun;14(2-3):331-41. doi: 10.1016/0169-5002(96)00557-0. Lung Cancer. 1996. PMID: 8794414 Clinical Trial.

5

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

Cottin V, Arpin D, Lasset C, Cordier JF, Brune J, Chauvin F, Trillet-Lenoir V. Cottin V, et al. Among authors: arpin d. Ann Oncol. 1999 Jul;10(7):809-15. doi: 10.1023/a:1008399831512. Ann Oncol. 1999. PMID: 10470428 Free article.

6

A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.

Claude L, Pérol D, Ginestet C, Falchero L, Arpin D, Vincent M, Martel I, Hominal S, Cordier JF, Carrie C. Claude L, et al. Among authors: arpin d. Radiother Oncol. 2004 May;71(2):175-81. doi: 10.1016/j.radonc.2004.02.005. Radiother Oncol. 2004. PMID: 15110451

7

[Angiogenesis and lung cancer].

Pérol M, Arpin D. Pérol M, et al. Among authors: arpin d. Bull Cancer. 2007 Jul;94 Spec No:S220-31. Bull Cancer. 2007. PMID: 17846008 Review. French.

8

[Tyrosine kinase inhibitors in the management of non-small cell lung cancer].

Pérol M, Arpin D. Pérol M, et al. Among authors: arpin d. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S188-97. Rev Mal Respir. 2007. PMID: 18235413 Review. French.

9

[Bevacizumab and non-small cell lung cancer: a new step?].

Pérol M, Arpin D. Pérol M, et al. Among authors: arpin d. Rev Mal Respir. 2009 Feb;26(2):125-38. doi: 10.1016/s0761-8425(09)71590-6. Rev Mal Respir. 2009. PMID: 19319108 French.

10

Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.

Duruisseaux M, Cadranel J, Biron E, Pérol M, Guérin JC, Arpin D. Duruisseaux M, et al. Among authors: arpin d. Lung Cancer. 2009 Sep;65(3):385-7. doi: 10.1016/j.lungcan.2009.02.018. Epub 2009 Apr 5. Lung Cancer. 2009. PMID: 19346028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters